Target Price | €55.00 |
Price | €42.18 |
Potential |
30.39%
register free of charge
|
Number of Estimates | 1 |
1 Analyst has issued a Eckert & Ziegler Strahlen- und Medizintechnik price target 2025.
The average Eckert & Ziegler Strahlen- und Medizintechnik target price is €55.00.
This is
30.39%
register free of charge
|
|
A rating was issued by 1 analysts: 1 Analysts recommend Eckert & Ziegler Strahlen- und Medizintechnik to buy, 0 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Eckert & Ziegler Strahlen- und Medizintechnik stock has an average upside potential 2025 of
30.39%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Revenue Million € | 246.09 | 277.70 |
10.72% | 12.84% | |
EBITDA Margin | 26.21% | 25.06% |
3.20% | 4.39% | |
Net Margin | 10.68% | 13.14% |
19.29% | 23.09% |
1 Analyst has issued a sales forecast Eckert & Ziegler Strahlen- und Medizintechnik 2024 . The average Eckert & Ziegler Strahlen- und Medizintechnik sales estimate is
This results in the following potential growth metrics:
1 Analyst has issued an EBITDA forecast Eckert & Ziegler Strahlen- und Medizintechnik 2024 . The average Eckert & Ziegler Strahlen- und Medizintechnik EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
1 Analyst has issued a net profit forecast Eckert & Ziegler Strahlen- und Medizintechnik 2024 . The average Eckert & Ziegler Strahlen- und Medizintechnik net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share € | 1.26 | 1.75 |
10.64% | 38.89% | |
P/E | 24.10 | |
EV/Sales | 3.01 |
1 Analysts have issued a Eckert & Ziegler Strahlen- und Medizintechnik forecast for earnings per share. The average Eckert & Ziegler Strahlen- und Medizintechnik <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the Eckert & Ziegler Strahlen- und Medizintechnik stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Eckert & Ziegler Strahlen- und Medizintechnik...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.